+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recurrent vascular access thrombosis in hemodialysis patients is associated with homozygosity for the 677CfwdarwT mutation in the methylene tetrahydrofolate reductase gene



Recurrent vascular access thrombosis in hemodialysis patients is associated with homozygosity for the 677CfwdarwT mutation in the methylene tetrahydrofolate reductase gene



Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 157A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033120613

Download citation: RISBibTeXText


Related references

Methylene tetrahydrofolate reductase 677CfwdarwT mutation analysis in caucasian women with early first trimester recurrent pregnancy loss. Blood 92(10 Suppl. 1 Part 1-2): 117B, 1998

Homozygous C fwdarw T mutation in the methylene tetrahydrofolate reductase gene does not increase the risk for venous thrombosis in patients with the factor V Leiden mutation. Blood 88(10 Suppl. 1 Part 1-2): 70B, 1996

Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 47(6): 324-329, 2001

The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thrombosis and Haemostasis 77(5): 818-821, 1997

The mutation ALA677 fwdarw VAL in the methylene tetrahydrofolate reductase gene A risk factor for premature arterial disease and venous thrombosis. Blood 88(10 Suppl. 1 Part 1-2): 285A, 1996

The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. American Journal of Kidney Diseases 41(3): 637-642, 2003

Does the prevalent mutation 677C-T in the methylene-tetrahydrofolate reductase gene contribute to hyperhomocysteinemia related to vascular disease?. American Journal of Human Genetics 59(4 Suppl. ): A195, 1996

Does the prevalent mutation 677 fwdarw T in the methylene-tetrahydrofolate reductase gene contribute to hyperhomocysteinemia related to vascular disease?. Blood 88(10 Suppl. 1 Part 1-2): 169A, 1996

Opposite impact of Methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation. Journal of Clinical Laboratory Analysis 32(5): E22401, 2018

Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. Journal of Obstetrics and Gynaecology 23(1): 55-58, 2003

Hyperhomocysteinemia in patients on antiepileptic drugs Relation to the mutation in the methylene-tetrahydrofolate reductase gene. Clinical Chemistry & Laboratory Medicine 39(Special Suppl.): S341, 2001

Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis. European Journal of Haematology 86(2): 167-172, 2011

Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Clinical and Laboratory Haematology 26(2): 143-146, 2004

Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Haematologia 32(4): 551-556, 2002

The effect of C677T mutation of methylene tetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele. Child's Nervous System 16(9): 559-563, 2000